YICHANG HEC CHANGJIANG PHARMACTL CO financial statements, including revenue, expenses, and profit
The total revenue of 1558 for the last semiannual is 1.38 B HKD, and it's 48.25% lower compared to the previous semiannual. The net income of H2 24 is -219.15 M HKD.